Medac
| Company type | GmbH (Private company) |
|---|---|
| Founded | 1970 |
| Headquarters | Wedel, Germany |
Area served | Worldwide[1] |
Key people | Frank Generotzky, Jörg Hans, Frank Lucaßen, Heiner Will |
| Revenue | approx. 551 Mio. EUR (2022/2023)[2] |
Number of employees | approx. 2000 (2024)[3] |
| Website | http://www.medac-group.com |
Medac GmbH (stylized as medac) is a German, worldwide operating pharmaceutical company based in Wedel near Hamburg and Tornesch, which is privately owned.
medac’s work focuses on the continuous improvement of already established pharmaceutical products, as well as on the development of new medicines in the fields of rheumatology, urology, hematology, and oncology. In addition, the company has extensive expertise in the diagnosis of infectious diseases and oncological diseases. The two wholly owned production subsidiaries in Dessau-Roßlau, Germany and in Brno, Czech Republic – produce, among other things, sterile medicines such as cytostatics.[4]
The manufactured medicines and diagnostics are delivered to over 90 countries worldwide. medac has subsidiaries and branches in Czech Republic, Denmark, Finland, France, Germany, Great Britain Italy, Japan, Norway, Poland, Portugal, Slovakia, Sweden, and in United Arab Emirates .[5]
History
In April 1970, medac was founded in Hamburg by Wilfried Mohr, Claus-Olaf Welding, Werner Mai, and Ernst Voss. The company initially focused on the production of coagulation preparations and fibrinolytics. During this period, diagnostic products (antibodies) were also marketed. Shortly thereafter, medac concentrated on the therapeutic area of oncology and began marketing the product Mitomycin C.[6]
Today, more than 50 oncological active substances in various dosage forms are offered for the treatment of numerous types of cancer, including BCG for intravesical instillation therapy in bladder cancer.[7]
In the late 1980s, a further therapeutic area emerged with the treatment of autoimmune diseases. medac is now one of the leading suppliers of methotrexate, a folic acid antagonist used in the treatment of rheumatoid arthritis, available in numerous dosages and in easily administrable forms.
Between 1997 and 2005, Schering AG held 25% of the company's shares.[8]
In May 2020, during the COVID-19 pandemic, medac presented an antibody test for SARS-CoV-2 as well as a PCR test for the direct detection of the virus.[9][10]
In October 2020, Medac, represented by a national law firm, prevailed before the European Court of Justice that the preparation Treosulfan, which Medac manufactured itself, was classified as an orphan drug.[11]
In January 2021, the drug Obnitix (cell therapy) developed by medac received the 2020 Innovation Prize from the German Pharmaceutical Journal (PZ).[12]
References
- ^ List of pharmaceutical manufacturers in the United Kingdom at de.wikipedia.org, called am 6. june 2012
- ^ Elektronischer Bundesanzeiger] bei ebundesanzeiger.de; retrieved, 27 November 2011
- ^ "About – Medac Group". medac-group.com. Retrieved March 11, 2026.
- ^ Büll, Frederik (2026-02-25). "Zu fünft an der Spitze: Pharma-Konzern Medac aus Wedel komplettiert Geschäftsführung". www.abendblatt.de (in German). Retrieved 2026-03-11.
- ^ [ license number Gliolan (EU/1/07/413/001-003)]
- ^ "Medac GmbH supports Guideline on Intravesical Instillations of BCG/MMC". European Medical Journal. 2015-05-11. Retrieved 2026-03-11.
- ^ 40 Jahre medac – Das Wachstum geht weiter. In: Deutsche Apotheker Zeitung vom 17. Februar 2011, S. 125
- ^ Bahr, Volker (July 3, 2020). "Hamburger Abendblatt (Pinneberg) - Reprint" (PDF). volker-bahr.de (in German). Retrieved March 11, 2026.
- ^ "Life Science Cluster für Hamburg und Schleswig-Holstein". www.lifesciencenord.de (in German). Retrieved 2026-03-11.
- ^ "medac Diagnostik: Komplettpaket für Covid-19-Testung". www.pressebox.de. 2020-05-08. Retrieved 2026-03-11.
- ^ Heidrich, Johanna (2020-10-02). "Medac gewinnt mit Preu Bohlig gegen EU-Kommission". juve.de (in German). Retrieved 2026-03-11.
- ^ GmbH, Avoxa-Mediengruppe Deutscher Apotheker. "PZ-Innovationspreis 2020: Zelltherapeutikum ausgezeichnet". Pharmazeutische Zeitung online (in German). Retrieved 2026-03-11.